Selection of the entity authorized to review and audit the Company’s financial statements in 2017
Current report 11/2017
Acting pursuant to Article 17(1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 2014 No 173, p. 1), the Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”), hereby discloses to the public that on 1 June 2017 the Supervisory Board of the Company adopted resolution No 1 on the selection of an entity authorized to:
- Review the Company’s financial statements for the reporting period ended 30 June 2017;
- Review the consolidated financial statements for the reporting period ended 30 June 2017;
- Audit the Company’s financial statements for the financial year ended 31 December 2017;
- Audit the consolidated financial statements for the financial year ended 31 December 2017.
The selection was made by the Supervisory Board in accordance with § 20(7) of the Company’s Articles of Association in conjunction with Article 66(4) of the Accounting Act of 29 September 1994 (consolidated text: Journal of Laws of 2016, item 1047, as amended).
The statutory auditor selected is CSWP Audyt Spółka z ograniczona odpowiedzialnością spółka komandytowa with its registered office in Warsaw, ul. Kopernika 34 (00-336), entered in the Register of Entrepreneurs of the National Court Register under KRS No 0000402544 and entered in the list of audit firms maintained by the National Council of Statutory Auditors under No 3767. The auditor was selected in compliance with the applicable regulations and professional standards.
The Company announces that it used the audit services of CSWP Audyt Spółka z ograniczoną odpowiedzialnością spółka komandytowa in the previous year.